$IRD 4 SEC Filings

Filed On	Filing
02 Oct 2026	Form 4: Foundation Fighting Blindness Retinal Degeneration Fund, Director and 1 other Sold 556,000 shares ($2.76M)
11 Sep 2026	Form 4: Magrath George, Director Received 392,157 shares by exercise or conversion ($451K) · Gave up 75,541 shares to cover exercise price or tax ($451K)
08 Sep 2026	Form 4: Gallagher Cam, Director Received 784,314 shares by exercise or conversion ($902K)
08 Sep 2026	Form 4: Gagnon Robert E., Chief Financial Officer Sold 28,000 shares ($127K)
27 Jul 2026	Form 4: Yerxa Benjamin R, Director Sold 7,429 shares ($22.1K)
27 Jul 2026	Form 4: Schachle Joseph K, Chief Operating Officer Sold 4,644 shares ($13.7K)
27 Jul 2026	Form 4: Magrath George, Director Sold 9,475 shares ($27.9K)
27 Jul 2026	Form 4: Gagnon Robert E., Chief Financial Officer Sold 7,783 shares ($22.9K)
20 May 2026	Form 4: Foundation Fighting Blindness Retinal Degeneration Fund, Director and 1 other Sold 1,700,000 shares ($7.4M)
27 Apr 2026	Form 4: Yerxa Benjamin R, Director Sold 7,470 shares ($39.1K)
27 Apr 2026	Form 4: Schachle Joseph K, Chief Operating Officer Sold 4,697 shares ($24.5K)
27 Apr 2026	Form 4: Zaremba Rabourn Amy, Head of Fin. Quality Assurance Sold 1,641 shares ($8.54K)
27 Apr 2026	Form 4: Magrath George, Director Sold 9,511 shares ($49.6K)
27 Apr 2026	Form 4: Jayagopal Ashwath, Chief Scientific & Dev. Ofc. Sold 7,542 shares ($39.2K)
27 Apr 2026	Form 4: Gagnon Robert E., Chief Financial Officer Sold 7,842 shares ($40.7K)
22 Apr 2026	Form 4: Rodgers Richard J, Director Received 24,367 shares as a grant or award
22 Apr 2026	Form 4: Manuso James S J, Director Received 24,367 shares as a grant or award
22 Apr 2026	Form 4: Graves Adrienne L, Director Received 24,367 shares as a grant or award
22 Apr 2026	Form 4: Gallagher Cam, Director Received 24,367 shares as a grant or award
22 Apr 2026	Form 4: Benton Susan, Director Received 24,367 shares as a grant or award

Comments